Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,559.98
(
0.53%
)
US TECH 100
29,416.40
(
0.82%
)
Dow Jones
50,667.84
(
0.05%
)
Brent Oil
92.18
(
-0.29%
)
Bitcoin
73,261.39
(
-2.17%
)
News Focus
News Focus
Post# of 257650
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123030
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 98716

Sunday, 10/31/2010 10:58:18 PM

Sunday, October 31, 2010 10:58:18 PM

Post# of 257650
More on the TMC435 PILLAR study (from the PR in #msg-56129587):

Small and transient bilirubin elevations (direct and indirect) were seen in the TMC435 150mg dose groups.

This is essentially the same language as in prior press releases; we’ll presumably have to wait for the actual AASLD presentation to know if there’s a safety problem here.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today